Mederi Therapeutics today announced the publication of a meta-analysis of 28 studies, representing 2468 patients who received Stretta Therapy to treat gastroesophageal reflux disease (GERD). The study entitled, “Systematic Review and Meta-Analysis of Controlled and Prospective Cohort Efficacy Studies of Endoscopic Radiofrequency for Treatment of Gastroesophageal Reflux Disease“, was published in Surgical Endoscopy. Authors included Ronnie Fass, MD, head of the Esophageal and Swallowing Center, Director of Gastroenterology and Hepatology at Metro Health Medical Center and Professor at Case Western University, and statistical expert Frederick Cahn, PhD, principal of Biomedical Strategies.

Lead author Dr. Ronnie Fass noted, “This comprehensive analysis combined our clinical expertise with Dr. Cahn’s statistical experience to produce the most thorough and objective review of currently available data. The results demonstrate that Stretta is a clinically effective and safe therapy for GERD.”

Read the full article here.